Abstract

The commercially available aromatic polyketones 1a-d were utilized for the synthesis of the multi-arm1,2,3-selenadiazole derivatives 3a-d. The preparation starts with the reaction between compounds 1a-d and p-toluenesulfonyl hydrazide to give the corresponding tosylhydrazones 2a-d. Subsequent reaction with selenium dioxide leads to regiospecific ring closure of the tosylhydrazones to give the target multi-arm 1,2,3-selenadiazole derivatives in high yield. A 1,2,3-selenadiazole derivative 3e containing an epoxide ring was also prepared. The structures of all the synthesized compounds were confirmed on the basis of spectral and analytical data. The compounds were screened in vitro for their antimicrobial activity against various pathogenic bacterial and Candida strains obtained from King Abdullah Hospital in Irbid -Jordan. Compounds 3a, 3c and 3e were found to be highly active against all the selected pathogens. Compound 3e showed an inhibition zone of 13 mm against the highly resistant P. aruginosa.

Highlights

  • Selenium containing heterocyclic compounds are of interest due to their biological and synthetic applications. 1,2,3-Selenadiazoles and derivatives are well known and have attracted attention as versatile synthetic intermediates [1,2]

  • In this paper we present new data on the antimicrobial activities of heterocyclic compounds containing 1,2,3-selenadiazole rings and the corresponding tosylhydrazones

  • The target 1,2,3-selenadiazole derivatives 3a-d were prepared from the corresponding tosylhydrazones 2a-d as shown in Scheme 1

Read more

Summary

Introduction

Selenium containing heterocyclic compounds are of interest due to their biological and synthetic applications. 1,2,3-Selenadiazoles and derivatives are well known and have attracted attention as versatile synthetic intermediates [1,2]. In this paper we present new data on the antimicrobial activities of heterocyclic compounds containing 1,2,3-selenadiazole rings and the corresponding tosylhydrazones.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.